GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 23 filers reported holding GAIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 90,000 | $434 | 0.52% |
| Greenlight Capital | 546,560 | $2,634,419 | 0.14% |
| Wealth Alliance Advisory Group, LLC | 12,502 | $60,260 | 0.02% |
| Cannell Capital | 12,371 | $59,628 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $280,042 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $289,200 | 0.01% |
| Tower Research Capital LLC (TRC) | 6,844 | $33 | 0.00% |
| NewEdge Advisors, LLC | 10,500 | $54,075 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,713 | $17,897 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |